Finnish Funding Agency for Innovation-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Finnish Funding Agency for Innovation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014012
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Finnish Funding Agency for Innovation (Tekes) is a financing organization that offers research and technological development programs. The organization offers financial services for research, development and novelty. It provides finance for research and development of new technologies, business concepts, networking and management practices. Tekes provides funding services for corporations, universities, research institutions, and government organizations, local and regional authorities. The organization concentrates on research and development collaboration in the areas of information and telecommunication technologies; biotechnology and healthcare systems; and nanotechnology, among others. The organization helps companies to enhance their networking and development potential. It has presence in Belgium, Finland, Russia, China, and the US. Tekes is headquartered in Helsinki, Finland.

Finnish Funding Agency for Innovation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Finnish Funding Agency for Innovation, Medical Devices Deals, 2011 to YTD 2017 9
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Euformatics Raises USD0.4 Million in Seed Financing 11
Blueprint Genetics Raises USD4 Million in Seed Venture Financing 12
DelSiTech Raises up to USD2.34 Million in Venture Financing 13
TILT Biotherapeutics Raises Funds through Seed Financing 14
Mobidiag Raises Funds Through Venture Financing 15
Plexpress Raises US$1.4 Million In Initial Closing Of Venture Financing Round 17
FKD Therapies Secures US$16 Million In Venture Financing 18
Finnish Funding Agency for Innovation – Key Competitors 19
Finnish Funding Agency for Innovation – Key Employees 20
Finnish Funding Agency for Innovation – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Government and Public Interest 22
Sep 14, 2016: Montisera receives major governmental funding from Tekes for initiating the pilot production of the company’s spruce hot water extract molecule 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Key Facts 2
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Finnish Funding Agency for Innovation, Deals By Therapy Area, 2011 to YTD 2017 8
Finnish Funding Agency for Innovation, Medical Devices Deals, 2011 to YTD 2017 9
Finnish Funding Agency for Innovation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Euformatics Raises USD0.4 Million in Seed Financing 11
Blueprint Genetics Raises USD4 Million in Seed Venture Financing 12
DelSiTech Raises up to USD2.34 Million in Venture Financing 13
TILT Biotherapeutics Raises Funds through Seed Financing 14
Mobidiag Raises Funds Through Venture Financing 15
Plexpress Raises US$1.4 Million In Initial Closing Of Venture Financing Round 17
FKD Therapies Secures US$16 Million In Venture Financing 18
Finnish Funding Agency for Innovation, Key Competitors 19
Finnish Funding Agency for Innovation, Key Employees 20
Finnish Funding Agency for Innovation, Other Locations 21
Finnish Funding Agency for Innovation, Subsidiaries 21

★海外企業調査レポート[Finnish Funding Agency for Innovation-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alexander & Baldwin Inc (ALEX):企業の財務・戦略的SWOT分析
    Alexander & Baldwin Inc (ALEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Zhejiang Sunflower Light Energy Science & Technology LLC (300111):電力:M&Aディール及び事業提携情報
    Summary Zhejiang Sunflower Light Energy Science & Technology LLC (Sunowe Solar) is an alternative energy company that produces and sells solar energy battery and components. The company’s products include polycrystalline silicon wafer, photovoltaic modules, and photovoltaic cells. Its photovoltaic c …
  • Denison Mines Corp (DNN):企業の財務・戦略的SWOT分析
    Denison Mines Corp (DNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Bausch Health Companies Inc (VRX):医療機器:M&Aディール及び事業提携情報
    Summary Bausch Health Companies Inc(Bausch Health) formerly known as Valeant Pharmaceuticals International Inc, develops, manufactures and markets several branded, over-the-counter (OTC) and generic drugs. The company also offers medical devices such as medical contact lenses, intraocular lenses, op …
  • Bioqual Inc (BIOQ):企業の財務・戦略的SWOT分析
    Summary Bioqual Inc (Bioqual) is a provider of contract research services which focuses on in vivo models of human diseases such as AIDS, influenza, RSV infection flavivirus infections including zika and dengue, malaria, hepatitis and cancer. The company evaluates vaccines, vaccine therapeutics, mic …
  • Kraftwerke Oberhasli AG:企業の戦略的SWOT分析
    Kraftwerke Oberhasli AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • McKinsey & Co Inc:企業の戦略的SWOT分析
    McKinsey & Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Litgrid AB (LGD1L):企業の財務・戦略的SWOT分析
    Litgrid AB (LGD1L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Pousadas de Portugal:企業の戦略・SWOT・財務情報
    Pousadas de Portugal - Strategy, SWOT and Corporate Finance Report Summary Pousadas de Portugal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Astellas Pharma Inc.:企業の戦略・SWOT・財務情報
    Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report Summary Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Bangkok Dusit Medical Services PCL (BDMS):企業の財務・戦略的SWOT分析
    Bangkok Dusit Medical Services PCL (BDMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • KT Corporation:企業の戦略・SWOT・財務情報
    KT Corporation - Strategy, SWOT and Corporate Finance Report Summary KT Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Eolus Vind AB (EOLU B):企業の財務・戦略的SWOT分析
    Summary Eolus Vind AB (Eolus Vind) is a wind farm developer that offers construction, development, and operation of green field projects and wind power plants. The company provides services such as consultancy services, administration, financing, development, and management of wind farms. It also of …
  • Active Biotech AB (ACTI):企業の財務・戦略的SWOT分析
    Active Biotech AB (ACTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Celonic AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Celonic AG (Celonic), a subsidiary of JRS Pharma LP is a biotechnology company that offers contract development manufacturing organization services. The company’s services include development of cell lines and biotechnological production processes, full GMP analytics, and manufacture of acti …
  • Petro-Hunt LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Petro-Hunt LLC (Petro-Hunt) is an oil and gas exploration and production company. The company offers services in the areas of pipeline exploration and production; gas processing, oil and gas technology; refining, real estate and ranching. Its exploration and production activities include dri …
  • Iterum Therapeutics Plc (ITRM):製薬・医療:M&Aディール及び事業提携情報
    Summary Iterum Therapeutics Plc (Iterum Therapeutics) is a clinical-stage pharmaceutical company which develops anti-infectives for multi-drug resistant (MDR) pathogens for treating serious and life-threatening diseases. The company is developing Sulopenem, an oral and IV targeted-spectrum penem ant …
  • Tav Havalimanlari Holding AS:戦略・SWOT・企業財務分析
    Tav Havalimanlari Holding AS - Strategy, SWOT and Corporate Finance Report Summary Tav Havalimanlari Holding AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Invicta Holdings Limited:企業の戦略・SWOT・財務情報
    Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Invicta Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • The Blackstone Group LP:企業のM&A・事業提携・投資動向
    The Blackstone Group LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Blackstone Group LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆